Initiating high-efficacy monoclonal antibody therapy before age 18 may reduce long-term disability in pediatric-onset multiple sclerosis.
Daily propionic acid supplements lowered levels of a nerve damage marker in people with MS, but clinical benefits remain ...
A review of a disability benefit is not expected to make "crude proposals" on changes to claimants' payments, the minister ...
Anil Menon, a NASA astronaut of Indian descent, is set to embark on an eight-month mission to the International Space Station ...
(Nasdaq: DFTX) (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address the underlying causes of psychiatric and ...
Extra.ie on MSN
Retailers fear ‘exodus’ of shoppers as North’s deposit scheme to pay more for bottle return
Retailers have warned that an incoming Re-Turnstyle deposit scheme in the North, which will pay higher rates per bottle, will ...
NOMINAL INDEXShashi v. Delhi Subordinate Service Selection Board And Ors 2026 LiveLaw (Del) 625 Abhijit Dipke v. Union of ...
A northwest project that helps children with complex needs who cannot access the ocean directly, has won a HSE innovation ...
Teva secures exclusive global rights to commercialize Polpharma Biologics’ biosimilar candidate to Ocrevus® (ocrelizumab), including both ...
Under the deal, Ottobock will inherit Fesia Technology’s portfolio of functional electrical stimulation (FES) products used ...
When China announced in 2021 that it had eradicated absolute poverty after an eight-year campaign, the achievement attracted ...
AI-guided CRISPR screening found two overlooked psoriasis targets, with topical gels reducing skin inflammation in mice as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results